BFBIO FY26 profit surges 41%
BF Biosciences Limited (PSX: BFBIO) reported a 41% surge in its net profit for the fiscal year ended June 30, 2026, reaching Rs632.13m compared to Rs447.15m in the preceding year.
September 29, 2026 (MLN): BF Biosciences Limited (PSX: BFBIO) reported a 41% surge in its net profit for the fiscal year ended June 30, 2026, reaching Rs632.13m compared to Rs447.15m in the preceding year. Reflecting this bottom-line performance, basic and diluted earnings per share (EPS) for the year expanded to Rs7.16, up from Rs5.52 in FY25. The primary drivers behind the performance were top-line volume expansio...